Introduction
Neonatal jaundice is the yellow discoloration of the sclera and skin caused by hyperbilirubinemia and is one of the most common conditions confronting neonatologists daily. About 60% of term and 80% of preterm neonates develop jaundice in the first week after birth [1] . Bilirubin encephalopathy in neonates, known as kernicterus, is a devastating brain injury, which can cause permanent neurodevelopmental handicap [2] .
Phototherapy has significant role in the prevention and treatment of unconjugated hyperbilirubinemia in neonates. Continuous phototherapy can produce adverse effects such as dehydration, temperature instability, skin rashes, loose stools, retinal damage, bronze baby syndrome, redistribution of blood flow and DNA damage [2, 3, 4] . A lesser known side effect, but potential complication of phototherapy is hypocalcemia (Hunter, 2004 ) [5] .
The neonates were clinically assessed for features of hypocalcemia i.e. jitteriness, irritability/ excitability, lethargy and convulsion, as well as other complication like rash, loose stool, fever and dehydration.
Ionized calcium is required for many biochemical processes including cell membrane integrity, blood coagulation, function of cell membrane, neuromuscular excitability and cellular enzymatic activity .The mechanism of phototherapy induced hypocalcemia in neonates, although not yet well understood, but seems to be accompanied by a decrease in serum melatonin concentration٫ which in turn is regulated by the pineal gland. Pineal gland in normal human, however, is shown to be influenced by the diurnal light dark cycle [6] .
There are still fewer studies on hypocalcaemic effect of phototherapy on the term and preterm newborns. Hence, phototherapy induced hypocalcemia is a significant problem. A few studies recommend that in order to prevent hypocalcemia due to phototherapy, babies should be given calcium as prophylaxis [7, 8] . 
II.
Methods And Materials
Study area:
The study was conducted in Departments of Pediatrics & Obstetrics & Gynaecology in NIMS Medical College, Jaipur, Rajasthan, India.
Study population:
A total of two hundred neonates (155 term and 45 preterm neonates) fulfilling the criteria of jaundice and requiring phototherapy enrolled during period from 1 st feb 2015 to 31 st july 2016
Study design:
This is hospital based prospective cross sectional study.
Inclusion criteria:
1) AGA (Appropriate for Gestational Age) neonates (term and preterm) who developed hyperbilirubinemia between ages 72 hours to 2 weeks of life.
2) Neonate requiring phototherapy according AAP guidelines [9] .
Exclusion criteria 1)
Neonates with Conjugated Hyperbilirubinemia.
2)
Neonates with co-morbidities like: Birth asphyxia, Septicemia, Renal failure 3) Abnormal electrolyte status detected before phototherapy
After going through detailed history and examination of neonates of AGA (Appropriate for Gestational Age) who developed hyperbilirubinemia between age 72 hours to 2 weeks of life a predesigned proforma was filled. A written and informed consent from parents or guardians was taken. Neonates fulfilling the above mentioned criteria underwent blood sampling from a peripheral vein for the estimation of serum bilirubin and serum calcium levels. Total serum bilirubin was estimated by using Jendrassik-Grof's method. Serum calcium was determined by Calcium Arsenazo III method [10] .
The neonates were subjected to 48 hours of continuous phototherapy from a distance of 45cm from the skin using a phototherapy unit comprising of 10 LED lamps with a wavelength range of 450-465nm and a spectral irradiance between 45µw/cm 2 /nm to 22µw/cm 2 /nm (GE Lullaby LED Phototherapy System). During exposure to phototherapy, the eyes of the neonates were shielded to prevent retinal damage and groin of male neonates were covered to protect the genitalia.
After 48 hours of continuous phototherapy, blood samples for total serum bilirubin and serum calcium were repeated. The results of serum calcium before and after 48 hours of photoherapy were analyzed.
Hypocalcemia was considered with serum calcium less than 7 mg/dl in preterm infants and less than 8mg/dl in term neonates [11] .The neonates were clinically assessed for features of hypocalcemia i.e. jitteriness, lethargy, apnea and convulsions. All neonates having hypocalcemia were treated as per the NICU protocol for hypocalcemia in neonates [11] .
Statistical analysis
It was performed using Quickcal (Instat) software. Paired t-test was used for comparing the calcium levels before and after 48 hours of phototherapy whereas Z-test for proportion was used to compare the various percentages of hypocalcemic neonates.
III. Observations And Results
The study was done on 200 neonates developing hyperbilirubinemia after 72 hours of life requiring phototherapy were included in the study. Out of these 200 neonates, 155 were term and 45 were preterm neonates. The mean chronological age was 5 days for both term and preterm neonates. The mean±SD weight of preterm neonates was 2.02±0.15 kilogram and the mean±SD weight for full term neonates was 2.66±0.17 kilogram.
After 48 hours of continuous phototherapy, serum calcium levels were significantly lowered in both term {62(40%);p<0.001} and preterm neonates {24(53.33%);p<0.001}. 
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IV. Discussion
Efficacy of phototherapy in the treatment and prevention of hyperbilirubinemia in newborn having unconjugated hyperbilirubinemia has been well established. Cord serum bilirubin (CSB) level ≤ 2mg/dl are considered safe while ≥2.1mg/dl are highly suggestive of babies who will develop neonatal hyperbilirubinemia [12] .
Hunter in 2004 hypothesized that phototherapy inhibits pineal secretion of melatonin which blocks the effect of cortisol on bone calcium. Cortiso if unchecked exerts a direct hypocalcemic effect and increases bone uptake of calcium as well [5] . In most normal term infants the plasma calcium level returns to normal by 10th day of life [13] .
In the present study, 45 preterms and 155 term babies enrolled were subjected to phototherapy. All the babies were more than 72 hrs of life to avoid the effect of early onset hypocalcemia as seen in babies in early neonatal period. After 48 hours of continuous phototherapy, serum calcium levels were significantly lowered in both preterm (p<0.001) and term neonates (p<0.001). While no significant difference were found between these two groups (p<0.247 ). Table no . 3 shows that in the present study jitteriness was observed in 33% of preterm and lethargy was observed in 16.67% of preterm and in the present jitteriness was observed in 11% of term neonates and lethargy was observed in10% of term neonates study after 48 hrs of phototherapy which is comparable to the study done by Arora et al (2014) [14] . This is suggestive that Jssssssitteriness and lethargy is main symptoms in phototherapy induce hypocalcemic newborns.
Correlation of the findings of the present study with the above mentioned studies indicates that there is a significant symptomatic hypocalcemia were found in preterm infants subjected to phototherapy.
V. Conclusion
Phototherapy is widely used in our clinical practice for the treatment of Neonatal hyperbilirubinemia, which is one of the common conditions as seen by paediatricians. Phototherapy induced hypocalcemia is a significant problem and there is a need for close monitoring of calcium levels in neonates subjected to phototherapy, which can leads to serious complications like Jitteriness, Lethargy, convulsions, apnea and irritability. Consideration of calcium supplementation as prophylaxis may be done in neonates subjected to phototherapy.
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